Book contents
- Clinical and Diagnostic Virology
- Reviews
- Clinical and Diagnostic Virology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Abbreviations
- Introduction
- Section 1 Individual Viruses
- Section 2 Other Related Agents
- Section 3 Clinical Syndromes
- Section 4 Laboratory Diagnosis
- Section 5 Patient Management
- Chapter 54 Antiviral Drugs
- Chapter 55 Viral Vaccines
- Chapter 56 Infection Control
- Chapter 57 Occupational Health
- Chapter 58 Public Health and Pandemic Preparedness
- Index
Chapter 55 - Viral Vaccines
from Section 5 - Patient Management
Published online by Cambridge University Press: 11 April 2024
- Clinical and Diagnostic Virology
- Reviews
- Clinical and Diagnostic Virology
- Copyright page
- Contents
- Preface
- Acknowledgements
- Abbreviations
- Introduction
- Section 1 Individual Viruses
- Section 2 Other Related Agents
- Section 3 Clinical Syndromes
- Section 4 Laboratory Diagnosis
- Section 5 Patient Management
- Chapter 54 Antiviral Drugs
- Chapter 55 Viral Vaccines
- Chapter 56 Infection Control
- Chapter 57 Occupational Health
- Chapter 58 Public Health and Pandemic Preparedness
- Index
Summary
This chapter provides details of the different kinds of vaccines available (live, attenuated, killed, inactivated, recombinant, subunit, mRNA, DNA and vector) for virus infections (e.g. SARS-CoV-2, HAV, HBV, influenzaviruses, JEE, measlesvirus, mumpsvirus, rubellavirus, HPV, rabies, polio, rotavirus, smallpox, mpox, yellow fever virus) in humans. It details the routes of administration and usage (e.g. pre-exposure or post-exposure, childhood, occupational health, travel and for at-risk groups).
Keywords
- Type
- Chapter
- Information
- Clinical and Diagnostic Virology , pp. 274 - 281Publisher: Cambridge University PressPrint publication year: 2024